Pt (IV) derivatives and nanocarriers comprising them
US10239903B2 · kind B2 · utility
1Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2015 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Apr 30, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are Pt (IV) lipophilic derivatives for improved drug performance in cancer therapy, as well as nanocarriers including the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.